Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice?

European Journal of Cancer

Volumn 42, Issue 1, 2006, Pages 8-16

  Tiseo, M ^a   Franciosi, V ^b   Grossi, F ^a   Ardizzoni, A ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b Azienda Ospedaliera Universitaria   (Italy)

Author keywords

Adjuvant chemotherapy; Adjuvant radiotherapy; Non small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; MITOMYCIN; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE; TEGAFUR; URACIL; VINBLASTINE; VINCA ALKALOID; VINDESINE;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; METASTASIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOLID TUMOR; SYSTEMATIC REVIEW; TREATMENT INDICATION;

EID: 29144454723     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.08.031     Document Type: Article

References (35)

1. D.M. Parkin Global cancer statistics in the year of 2000 Lancet Oncol 2 2001 533 543
2. A. Jemal, T. Murray, and E. Ward Cancer statistics 2005 CA Cancer J Clin 55 2005 10 30
3. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
4. R. Feld, L.V. Rubinstein, and T.H. Weisenberger Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies J Clin Oncol 2 1984 1352 1358
5. P.C. Pairolero, D.E. Williams, and E.J. Bergstralh Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease Ann Thorac Surg 38 1984 331 338
6. P. Thomas, and L. Rubinstein Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung cancer study group Ann Thorac Surg 49 1990 242 247
7. N. Martini, B.J. Flehinger, and M.B. Zaman Prospective study of 445 lung carcinomas with mediastinal lymph node metastases J Thorac Cardiovasc Surg 80 1980 390 399
8. PORT Meta-analysis Trialist Group Post-operative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patients data from nine randomized controlled trials Lancet 352 1998 257 263
9. Anonymous Effects of post-operative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung: the lung cancer study group N Engl J Med 315 1986 1377 1381
10. L. Norton, and R. Simon Tumor size, sensitivity to therapy and the design of treatment protocols Cancer Treat Rep 61 1977 1307 1317
11. J.S. Macdonald Clinical overview: adjuvant therapy of gastrointestinal cancer Cancer Chemother Pharmacol 54 Suppl. 1 2004 4 11
12. A. Spira, and D.S. Ettinger Multidisciplinary management of lung cancer N Engl J Med 350 2004 379 392
13. D.G. Pfister, D.H. Johnson, and C.G. Azzoli American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 2004 330 353
14. H. Wagner jr., and P. Bonomi Preoperative and post-operative therapy for non-small cell lung cancer J.A. Roth J.C. Ruckdeschel T.H. Weisenburger Thoracic oncology 1995 W.B. Saunders Philadelphia, PA 147 163
15. S. George, M.J. Schell, and F.C. Detterbeck Adjuvant chemotherapy for resected non-small cell carcinoma of the lung: why we still don't know Oncologist 3 1998 35 44
16. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials BMJ 311 1995 899 909
17. S.M. Keller, S. Adak, and H. Wagner A randomized trial of post-operative adjuvant therapy in patients with completely resected stage II or IIIA non-small cell lung cancer N Engl J Med 343 2000 1217 1222
18. G.V. Scagliotti, R. Fossati, and V. Torri Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIA non-small cell lung cancer J Natl Cancer Inst 95 2003 1453 1461
19. L. Crinò, M. Clerici, and F. Figoli Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.) Ann Oncol 6 1995 347 353
20. R. Arriagada, B. Bergman, and A. Dunant Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
21. D. Waller, M.D. Peake, and R.J. Stephens Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg 26 2004 173 182
22. H. Tada, R. Tsuchiya, and Y. Ichinose A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304) Lung Cancer 43 2004 167 173
23. H. Kato, Y. Ichinose, and M. Ohta A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 22 2004 1713 1721
24. M. Nakagawa, F. Tanaka, and N. Tsubota A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG) - the 4th study Ann Oncol 16 2005 75 80
25. C. Hamada, M. Ohta, and H. Wada Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small cell lung cancer Proc Am Soc Clin Oncol 22 2004 14S [abstr. 7002]
26. C.J. Langer The role of tegafur/uracil in pulmonary malignancy Drugs 58 Suppl. 3 1999 71 75
27. T.L. Winton, R. Livingston, and D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer N Engl J Med 352 2005 2589 2597
28. F. Shepherd, T. Winton, and R. Livingston The impact of adjuvant vinorelbine (VIN) and cisplatin (CIS) on quality of life (QoL): Results from The National Cancer Institute of Canada Clinical Trials Group Trial BR.10 randomized trial of VIN/CIS versus observation in stage IB and II non-small cell Ann Oncol 15 Suppl. 3 2004 [abstr. 6270]
29. G.M. Strauss, J. Herndon, and M.A. Maddaus Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) protocol 9633 Proc Am Soc Clin Oncol 22 2004 14S [abstr. 7019]
30. J. Douillard, R. Rosell, and M. Delena ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small cell lung cancer (NSCLC) patients (pts): final results after 70 months median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association Proc Am Soc Clin Oncol 23 2005 624S [abstr. 7013]
31. K. Hotta, K. Matsuo, and H. Ueoka Role of adjuvant chemotherapy in patients with resected non-small cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials J Clin Oncol 22 2004 3860 3867
32. A. Sedrakyan, J. van Der Meulen, and K. O'Byrne Post-operative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis J Thorac Cardiovasc Surg 128 2004 414 419
33. E. Bria, R.J. Gralla, and H. Raftopoulos Does adjuvant chemotherapy improve survival in non-small cell lung cancer (NSCLC)? A pooled-analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit Proc Am Soc Clin Oncol 23 2005 655S [abstr. 7140]
34. Early Breast Cancer Trialists' Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31 000 recurrences and 24 000 deaths among 75 000 women Lancet 339 1992 71 85
35. International Multicenter Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995, 343, 939-44.